Plasma-Derived Therapies Market - By Product: Immunoglobulins, Coagulation Factors, Albumin, Others. By Indication: Hemophilia, Immunodeficiency Disorders, Neurological Disorders, Others. By End-user: Hospitals, Specialty Clinics, Homecare. By Distribution Channel: Direct Sales, Distributors. By Region: North America, Europe, Asia-Pacific, Latin America, Middle East & Africa.
9.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
9.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
9.6 Global Plasma-Derived Therapies Market - Opportunity Analysis Index,
By Product,
By Indication,
By End-user,
By Distribution Channel,
and Region, 2024 - 2031
10. North America Global Plasma-Derived Therapies Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
10.1 By Product Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
10.1.1 Immunoglobulins
10.1.2 Coagulation Factors
10.1.3 Albumin
10.1.4 Others
10.2 By Indication Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
10.2.1 Hemophilia
10.2.2 Immunodeficiency Disorders
10.2.3 Neurological Disorders
10.2.4 Others
10.3 By End-user Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
10.3.1 Hospitals
10.3.2 Specialty Clinics
10.3.3 Homecare
10.4 By Distribution Channel Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
10.4.1 Direct Sales
10.4.2 Distributors.
10.5 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
10.5.1 United States
10.5.2 Canada
10.6 North America
Global Plasma-Derived Therapies Market – Opportunity Analysis Index,
By Product,
By Indication,
By End-user,
By Distribution Channel,
and Country, 2024 - 2031
10.7 Regional Trends Analysis
10.8 North America Global Plasma-Derived Therapies Market Research Report - Company Profiles
10.8.1 Company 1 (United States)
10.8.2 Company 2 (Canada)
10.8.3 Company 3 (Canada)
11. Europe Global Plasma-Derived Therapies Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
11.1 By Product Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
11.1.1 Immunoglobulins
11.1.2 Coagulation Factors
11.1.3 Albumin
11.1.4 Others
11.2 By Indication Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
11.2.1 Hemophilia
11.2.2 Immunodeficiency Disorders
11.2.3 Neurological Disorders
11.2.4 Others
11.3 By End-user Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
11.3.1 Hospitals
11.3.2 Specialty Clinics
11.3.3 Homecare
11.4 By Distribution Channel Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
11.4.1 Direct Sales
11.4.2 Distributors.
11.5 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
11.5.1 Germany
11.5.2 United Kingdom
11.5.3 France
11.5.4 Spain
11.5.5 Italy
11.5.6 Russia
11.5.7 Netherlands
11.5.8 Poland
11.5.9 Rest of Europe
11.6 Europe
Global Plasma-Derived Therapies Market – Opportunity Analysis Index,
By Product,
By Indication,
By End-user,
By Distribution Channel,
and Country, 2024 - 2031
11.7 Regional Trends Analysis
11.8 Europe Global Plasma-Derived Therapies Market Research Report - Company Profiles
11.8.1 Company 1 (Germany)
11.8.2 Company 2 (United Kingdom)
11.8.3 Company 3 (United Kingdom)
12. Asia-Pacific Global Plasma-Derived Therapies Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
12.1 By Product Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
12.1.1 Immunoglobulins
12.1.2 Coagulation Factors
12.1.3 Albumin
12.1.4 Others
12.2 By Indication Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
12.2.1 Hemophilia
12.2.2 Immunodeficiency Disorders
12.2.3 Neurological Disorders
12.2.4 Others
12.3 By End-user Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
12.3.1 Hospitals
12.3.2 Specialty Clinics
12.3.3 Homecare
12.4 By Distribution Channel Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
12.4.1 Direct Sales
12.4.2 Distributors.
12.5 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
12.5.1 China
12.5.2 Japan
12.5.3 India
12.5.4 South Korea
12.5.5 Australia & NZ
12.5.6 ASEAN
12.5.7 Rest of Asia-Pacific
12.6 Asia-Pacific
Global Plasma-Derived Therapies Market – Opportunity Analysis Index,
By Product,
By Indication,
By End-user,
By Distribution Channel,
and Country, 2024 - 2031
12.7 Regional Trends Analysis
12.8 Asia-Pacific Global Plasma-Derived Therapies Market Research Report - Company Profiles
12.8.1 Company 1 (China)
12.8.2 Company 2 (Japan)
12.8.3 Company 3 (Japan)
13. Latin America Global Plasma-Derived Therapies Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
13.1 By Product Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
13.1.1 Immunoglobulins
13.1.2 Coagulation Factors
13.1.3 Albumin
13.1.4 Others
13.2 By Indication Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
13.2.1 Hemophilia
13.2.2 Immunodeficiency Disorders
13.2.3 Neurological Disorders
13.2.4 Others
13.3 By End-user Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
13.3.1 Hospitals
13.3.2 Specialty Clinics
13.3.3 Homecare
13.4 By Distribution Channel Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
13.4.1 Direct Sales
13.4.2 Distributors.
13.5 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
13.5.1 Brazil
13.5.2 Mexico
13.5.3 Argentina
13.5.4 Peru
13.5.5 Colombia
13.5.6 Rest of Latin America
13.6 Latin America
Global Plasma-Derived Therapies Market – Opportunity Analysis Index,
By Product,
By Indication,
By End-user,
By Distribution Channel,
and Country, 2024 - 2031
13.7 Regional Trends Analysis
13.8 Latin America Global Plasma-Derived Therapies Market Research Report - Company Profiles
13.8.1 Company 1 (Brazil)
13.8.2 Company 2 (Mexico)
13.8.3 Company 3 (Mexico)
14. Middle East & Africa Global Plasma-Derived Therapies Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
14.1 By Product Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
14.1.1 Immunoglobulins
14.1.2 Coagulation Factors
14.1.3 Albumin
14.1.4 Others
14.2 By Indication Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
14.2.1 Hemophilia
14.2.2 Immunodeficiency Disorders
14.2.3 Neurological Disorders
14.2.4 Others
14.3 By End-user Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
14.3.1 Hospitals
14.3.2 Specialty Clinics
14.3.3 Homecare
14.4 By Distribution Channel Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
14.4.1 Direct Sales
14.4.2 Distributors.
14.5 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
14.5.1 Saudi Arabia
14.5.2 UAE
14.5.3 South Africa
14.5.4 Egypt
14.5.5 Israel
14.5.6 Rest of Middle East and Africa
14.6 Middle East & Africa
Global Plasma-Derived Therapies Market – Opportunity Analysis Index,
By Product,
By Indication,
By End-user,
By Distribution Channel,
and Country, 2024 - 2031
14.7 Regional Trends Analysis
14.8 Middle East & Africa Global Plasma-Derived Therapies Market Research Report - Company Profiles
14.8.1 Company 1 (Saudi Arabia)
14.8.2 Company 2 (UAE)
14.8.3 Company 3 (UAE)
15. Competition Landscape
15.1 Strategic Dashboard of Top Market Players
15.2 Company Profiles (Introduction, Financial Assessments, Portfolio of Offerings, Milestones and Achievements, Strategic Initiative, and SWOT Analysis)
15.2.1 CSL Behring
15.2.2 Grifols S.A.
15.2.3 Takeda Pharmaceutical Company
15.2.4 Octapharma AG
15.2.5 Kedrion Biopharma
15.2.6 LFB Group
15.2.7 Biotest AG
15.2.8 Sanquin
15.2.9 China Biologic Products Holdings
15.2.10 BPL (Bio Products Laboratory).
16. Data Collection Method and Research Approach 17. Principal Presumptions and Acronyms
Methodology & Credibility
Built for enterprise decisions, not vanity metrics.
Triangulated Sizing
Bottom-up, top-down, and peer benchmarks reconciled by analysts.
Primary + Secondary Research
Executive interviews combined with validated public and paid sources.
Scenario & Sensitivity
Base, bull and bear cases to stress-test strategic moves.
Need Confidence Fast?
We’ll map your questions to the report in 15 minutes.